Clinical Research
Opportunities

Penn Medicine is conducting studies to develop new ways to prevent, diagnose, and treat disease. You might be eligible to participate

Get started

Penn Medicine is conducting studies to develop new ways to prevent, diagnose, and treat disease. You might be eligible to participate

Get started

Penn Medicine is conducting medical studies to develop new diagnostic and clinical treatments to improve current standards of care.

Search by keywords

Please select a valid location from the dropdown

Browse by Condition or Principal Investigator

Browse all Trials

Featured studies

Recently added/updated trials

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

18 years - 80 years
All genders
Phase 2/3
Interventional
This pivotal phase 2/3, multi-center, adaptive design study of L-Annamycin for Injection in combination with Cytarabine Injection as second line therapy for remission induction in adult subjects with refractory/relapsed AML is divided into two parts, Part A and Part B.
Learn More

Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit

21 years or above
Accepts healthy volunteer
All genders
This study aims to investigate harm-reduction sampling in a choice format versus medicinal nicotine sampling on smoking behavior, identify mechanisms of sampling's effects, and explore moderators of these effects among a national sample of people unmotivated to quit smoking. Participants will be randomized 2:1 to choose one of two harm-reduction products (ECIG, ONP) versus a medicinal nicotine control condition (nicotine patch + lozenge, NPL), receive a 4-week starter product regimen, and then be followed for 6 months to assess use behavior.
Learn More

A Randomized, Placebo-controlled, Double-blind, Multicenter Study to Assess the Efficacy and Safety of Nipocalimab in Adults with Primary Sjogren's Syndrome (pSS)

18 years - 75 years
All genders
Phase 2
Interventional
The purpose of this study is to evaluate the efficacy and safety of nipocalimab in participants with primary Sjogren's syndrome (pSS) versus placebo.
Check Eligibility

Volunteer Sign-Up

If you don’t see a trial that fits your needs, consider joining our research volunteer registry. By signing up, you’ll be notified if a study matches your background and health profile.

Sign Up Now

Healthy Volunteers

Clinical research studies currently seeking healthy individuals.

View Studies

Virtual Studies

Also called Online or Decentralized studies. Some may be a mix of remote and in-person visits. 

View Studies

Logo

Penn Medicine experts answer questions from patient advocates and share groundbreaking medical developments happening at the University of Pennsylvania.

View More